Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-β-d-arabinofuranosyluracil ([18F]-FMAU)

Nuclear Medicine and Biology

Volumn 39, Issue 7, 2012, Pages 1019-1025

  Chen, Kai ^a   Li, Zibo ^a   Conti, Peter S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

18F FMAU; Automated synthesis; Friedel Crafts catalyst; Microwave assisted; PET probe

Indexed keywords

CLEVUDINE F 18; RADIOPHARMACEUTICAL AGENT; THYMINE DERIVATIVE; TRIFLUOROMETHANESULFONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG STRUCTURE; FRIEDEL CRAFTS REACTION; HEATING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MICROWAVE ASSISTED ONE POT RADIOSYNTHESIS; MICROWAVE RADIATION; ONE POT SYNTHESIS; RADIOCHEMISTRY; REACTION TIME; RELIABILITY; TEMPERATURE;

ARABINOFURANOSYLURACIL; CHEMISTRY TECHNIQUES, SYNTHETIC; FLUORINE RADIOISOTOPES; MICROWAVES; RADIOCHEMISTRY;

EID: 84866042648     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.03.003     Document Type: Article

References (45)

1. Perlman M.E., Conti P.S., Schmall B., Watanabe K.A. Synthesis and purification of the anti-viral agent 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125. Int J Nucl Med Biol 1984, 11:215-218.
2. 82Br]-5-halo-1-(2-Deoxy-2-fluoro-b-d-arabinofuranosyl)uracils. Appl Radiat Isot 1986, 37:901-905.
3. Grierson JR, Shields AF, C JH. Radiosynthesis for 2'-deoxy-1-[C-11]methyl-psuedouridine, an isostere of labeled thymidine, as an agent for the measurement of DNA synthesis in vivo. J Label Comp Radiopharm 1994;35:290-291.
4. Grierson J.R., Shields A.F., Link J.J. Radiosynthesis of (C-11)methyl-labeled AZT from (C-11)methyliodide. J Label Comp Radiopharm 1995, 37:608-609.
5. 11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET. Nucl Med Biol 1995, 22:783-789.
6. 11C]-FMAU) Initial clinical studies. J Nucl Med 2002, 43:26P.
7. Shields A.F., Grierson J.R., Kozawa S.M., Zeng M. Development of labeled AZT for imaging tumor proliferation. J Nucl Med 1995, 36:208P.
8. Shields A.F., Grierson J.R., Dohmen B.M., Machulla H.J., Stayanoff J.C., Lawhorn-Crews J.M., et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998, 4:1334-1336.
9. Bading J.R., Shields A.F. Imaging of cell proliferation: status and prospects. J Nucl Med 2008, 49(Suppl 2):64S-80S.
10. Eriksson S., Kierdaszuk B., Munch-Petersen B., Oberg B., Johansson N.G. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun 1991, 176:586-592.
11. Kong X.B., Zhu Q.Y., Vidal P.M., Watanabe K.A., Polsky B., Armstrong D., et al. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother 1992, 36:808-818.
12. Grierson J.R., Schwartz J.L., Muzi M., Jordan R., Krohn K.A. Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol 2004, 31:829-837.
13. Chou T.C., Kong X.B., Fanucchi M.P., Cheng Y.C., Takahashi K., Watanabe K.A., et al. Synthesis and biological effects of 2'-fluoro-5-ethyl-1-beta-d-arabinofuranosyluracil. Antimicrob Agents Chemother 1987, 31:1355-1358.
14. 18F]-FMAU). J Label Compd Radiopharm 2002, 45:583-590.
15. 18F] labelled 2'-deoxy-2'-fluoro-1-beta-d-arabinofuranosyluracil and its 5-substituted nucleosides. J Label Comp Radiopharm 2003, 46:285-289.
16. 18F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol 2003, 30:215-224.
17. 14C]FMAU) in rat prostate tumor cells. Nucl Med Biol 2000, 27:361-368.
18. Bading J.R., Shahinian A.H., Vail A., Bathija P., Koszalka G.W., Koda R.T., et al. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-d-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol 2004, 31:407-418.
19. 18F-FMAU and PET. J Nucl Med 2005, 46:292-296.
20. 18F]FMAU and positron emission tomography in patients with cancer. Eur J Nucl Med Mol Imaging 2005, 32:15-22.
21. 18F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. Cancer Res 2002, 62:3331-3334.
22. 18F-FLT)-a pilot study. Eur J Surg Oncol 2006, 32:39-43.
23. Buck A.K., Bommer M., Stilgenbauer S., Juweid M., Glatting G., Schirrmeister H., et al. Molecular imaging of proliferation in malignant lymphoma. Cancer Res 2006, 66:11055-11061.
24. 18F-fluorothymidine in patients with gliomas. J Nucl Med 2006, 47:1612-1621.
25. 18F]-FIAU). Nucl Med Biol 2010, 37:439-442.
26. 18F]-FMAU) using a one reactor radiosynthesis module. Nucl Med Biol 2011, 38:201-206.
27. 18F]FMAU). Curr Radiopharm 2011, 4:24-30.
28. 18F]-FMAU using a novel dual reactor radiosynthesis module. J Label Compd Radiopharm 2009, 52:553-558.
29. Tann C.H., Brodfuehrer P.R., Brundidge S.P., Sapino C., Howell H.G. Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodouracil (beta-FIAU) and 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)thymine (beta-FMAU). J Org Chem 1985, 50:3644-3647.
30. 18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression. Mol Imaging Biol 2008, 10:82-91.
31. 18F]SFB). J Vis Exp 2011, 2755.
32. Massoud T.F., Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003, 17:545-580.
33. Weissleder R., Mahmood U. Molecular imaging. Radiology 2001, 219:316-333.
34. Chen K., Conti P.S. Target-specific delivery of peptide-based probes for PET imaging. Adv Drug Deliv Rev 2010, 62:1005-1022.
35. Chen K., Chen X. Positron emission tomography imaging of cancer biology: current status and future prospects. Semin Oncol 2011, 38:70-86.
36. Polshettiwar V., Varma R.S. Aqueous microwave chemistry: a clean and green synthetic tool for rapid drug discovery. Chem Soc Rev 2008, 37:1546-1557.
37. Roberts B.A., Strauss C.R. Toward rapid, ' green', predictable microwave-assisted synthesis. Acc Chem Res 2005, 38:653-661.
38. Santagada V., Frecentese F., Perissutti E., Fiorino F., Severino B., Caliendo G. Microwave assisted synthesis: a new technology in drug discovery. Mini Rev Med Chem 2009, 9:340-358.
39. Kallmerten A.E., Alexander A., Wager K.M., Jones G.B. Microwave accelerated labeling methods in the synthesis of radioligands for positron emission tomography imaging. Curr Radiopharm 2011, 4:343-354.
40. 18F]LBT999: selective dopamine transporter ligands for quantitative molecular imaging by means of PET. Bioorg Med Chem 2009, 17:7630-7634.
41. 18F]fluorinated fatty acid analogs. Nucl Med Biol 2011, 38:435-441.
42. Stone-Elander S., Elander N. Microwave applications in radiolabelling with short-lived positron-emitting radionuclides. J Label Compd Radiopharm 2002, 45:715-746.
43. 18F]SFB), and its use in microwave-enhanced radiochemical coupling reactions. J Label Compd Radiopharm 2010, 53:586-591.
44. 18F]β-fluoroethyl tosylate under microwave-enhanced conditions. J Label Compd Radiopharm 2004, 47:289-297.
45. Jacobson O., Zhu L., Ma Y., Weiss I.D., Sun X., Niu G., et al. Rapid and simple one-step F-18 labeling of peptides. Bioconjug Chem 2011, 22:422-428.